FDA approves first MRNA flu vaccine for adults over 50
The FDA has announced the approval of M-Fluciva, the first flu shot utilizing mRNA technology, marking a significant advance in vaccination methods. Traditional vaccines require longer manufacturing times, but mRNA vaccines like M-Fluciva can be produced much more quickly.
© CNN